# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-032694
Filing Date
2026-03-20
Accepted
2026-03-20 16:05:49
Documents
19
Period of Report
2026-05-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | tm261499-3_def14a.htm iXBRL | DEF 14A | 607915
6 | GRAPHIC | bc_comptsr-4c.jpg | GRAPHIC | 57837
7 | GRAPHIC | bc_netincome-4c.jpg | GRAPHIC | 53724
8 | GRAPHIC | lg_markertherapeutics-4clr.jpg | GRAPHIC | 31700
9 | GRAPHIC | px_26markertheproxy1pg01-bw.jpg | GRAPHIC | 327875
10 | GRAPHIC | px_26markertheproxy1pg02-bw.jpg | GRAPHIC | 234633
| Complete submission text file | 0001104659-26-032694.txt |  | 2977402

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | mrkr-20251231.xsd | EX-101.SCH | 7987
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mrkr-20251231_def.xml | EX-101.DEF | 3606
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mrkr-20251231_lab.xml | EX-101.LAB | 25730
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mrkr-20251231_pre.xml | EX-101.PRE | 6096
24 | EXTRACTED XBRL INSTANCE DOCUMENT | tm261499-3_def14a_htm.xml | XML | 87211

Mailing Address 2450 HOLCOMBE BLVD TMC PARTNERS OFFICE 1.311 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD TMC PARTNERS OFFICE 1.311 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37939 | Film No.: 26778271
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)